ESGO 2017 congress, November 4-7, 2017 in Vienna, Austria

Quality Indicators for the surgical treatment of endometrial carcinoma

Based on the ESGO-ESTRO-ESP Endometrial cancer guidelines developed from 2019-2020, 29 structural, process and outcome indicators were defined. They are related to center case olad, training, experience of the surgeon, structured multi-disciplinarity of the team and active participation in clinical research. Two indicators ar related to the adequate pre-operative invetsigations, 14 to peri-operative standards of care. One indicator is related to molecular markeers for endometrial carcinoma diagnosis and determinants for treatment decisions. Another quality indicator is dedicated to the management of patients after primary surgical treatment and last five indicators highlight the need for a systematic assessment of surgical morbidity and oncologic outcome. An assessment form including a scoring systém was built as a basis for ESGO accreditation of centrs for endometrial cancer surgery.

The article was published in December 2021 and is available here: ESGO Quality Indicators for the surgical treatment of endometrial carcinoma. You can read it HERE.

Name	Specialty	Affiliation
Nadeem Abu-Rustum	Gynaecological Oncologist	Memorial Sloan Kettering Cancer Center, New York (USA)
Beyhan Ataseven	Gynaecological Oncologist	Evangelische kliniken Essen-Mitte, University Hospital Munich (Germany)
David Cibula	Gynaecological Oncologist	First Faculty of Medicine, General University Hospital of Charles University in Prague (Czech Republic)
Nicole Concin	Gynaecological Oncologist (Chair)	Innsbruck Medical University (Austria), Evangelische kliniken Essen-Mitte (Germany)
Anna Fagotti	Gynaecological Oncologist	Fondazione Policlinico Universitario A.Gemelli IRCCS, Rome (Italy)
Christina Fotopoulou	Gynaecological Oncologist	Imperial College London Faculty of Medicine, London (UK)
Pawel Knapp	Gynaecological Oncologist	University Oncology Center, Medical University of Bialystok (Poland)
Christian Marth	Gynaecological Oncologist	Innsbruck Medical University (Austria)
Philippe Morice	Gynaecological Oncologist	Institut Gustave Roussy, Villejuif, Paris (France)
Jan Persson	Gynaecological Oncologist (Chair)	Skåne University Hospital, Lund University, Faculty of Medicine, Clinical Sciences, Lund (Sweden)
Denis Querleu	Gynaecological Oncologist	Fondazione Policlinico Universitario A.Gemelli IRCCS, Rome (Italy), University Hospital Strasbourg (France)
Jalid Sehouli	Gynaecological Oncologist	Campus Virchow Klinikum, Charite-Universtätsmedizin Berlin, Corporate Member of Freie Universität zu Berlin and Berlin Institute of Health, Berlin (Germany)
Artem Stepanyan	Gynaecological Oncologist	Nairi Medical Center, Yerevan (Armenia)
Cagatay Taskiran	Gynaecological Oncologist	Koç University School of Medicine, Ankara, VKV American Hospital, Istanbul (Turkey)
Ignace Vergote	Gynaecological Oncologist	Leuven Cancer Institute, Catholic University Leuven (Belgium)
Pauline Wimberger	Gynaecological Oncologist	Department of Gynecology and Obstetrics, Technische Universität Dresden, National Center for Tumour Diseases, Dresden, German Cancer Research Center, Heidelberg, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Medizinische Fakultat Carl Gustav Carus, Dresden, Helmholtz-Zentrum Dresden-Rossendorf (Germany)
Ignacio Zapardiel	Gynaecological Oncologist	La Paz University Hospital - IdiPAZ, Madrid (Spain)